期刊文献+

放射治疗乳腺癌术后胸壁复发64例临床分析 被引量:7

Radiotherapy for 64 cases with postoperative chestwall local recurrence of breast cancer
下载PDF
导出
摘要 目的总结乳腺癌改良根治术后胸壁局部复发的临床特点及放疗疗效。方法回顾性分析64例乳腺癌改良根治术后胸壁复发患者的临床资料。结果放射治疗对于局部病灶直径<2 cm的疗效较好,64例无一例先出现锁骨上淋巴结转移,5例局部晚期乳腺癌胸壁复发在术后半年内。结论 (1)单个病灶直径≥2 cm放疗效果差,建议手术;(2)照射胸壁须照射锁骨上;(3)锁骨上淋巴结转移,不必作胸壁预防照射;(4)对于局部晚期的,放疗时间不应晚于术后3月。 Aim To Summarize clinical features and effect of radiotherapy in breast cancer after modified radical mastectomy chest wall recurrence.Methods Retrospective analysis was made of 64 cases of breast cancer after modified radical mastectomy chest wall recurrence in patients with clinical data.Results Radiation therapy for diameter 〈2 cm had good effects,None of the 64 cases developed supraclavicular lymph node metastasis.5 cases of locally advanced breast cancer chest wall recurrence developed within six months after surgery.Conclusion For single lesion ≥ 2 cm,radiotherapy is poor so surgery is recommended.Supraclavicular region of chest wall should accept irradiation.If there is supraclavicular lymph node metastasis,there is no need to have chest wall irradiation.For locally advanced recurrence,radiation time should not be later than 3 months after operation.
出处 《安徽医药》 CAS 2011年第12期1530-1531,共2页 Anhui Medical and Pharmaceutical Journal
关键词 乳腺癌 胸壁复发 放射治疗 breast cancer chest wall recurrence radiation therapy
  • 相关文献

参考文献8

二级参考文献43

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008 [ J ]. CA Cancer J Clin ,2008,58(2) :71 -96.
  • 2Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics,2002 [J]. CA Cancer J Clin,2005,55(2) :74 - 108.
  • 3Kouroussis C, Kakolyris S, Mavroudis D, et al. A dose - finding study of the weekly administration of paclitaxel in patients with advanced solid tumors [ J ]. Am J Clin Onco1,2001,24 (4) :404 - 7.
  • 4Jones SF, Greco FA, Hainsworth JD, et al. A phase I trial of weekly paclitaxel plus prolonged oral eniluracil/5-fluorouracil in patients with refractory malignancies [ J ]. Oncologist,2002,7 (5) :444 - 50.
  • 5Androulakis N, Kouroussis C, Mavroudis D, et al. Phase Ⅰ study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid turnouts [ J ]. Eur J Cancer, 2002,38 ( 15 ) : 1992 - 7.
  • 6Di Costanzo F,Gasperoni S,Papaldo P,et al. Weekly paelitaxel plus capecitabine in advanced breast cancer patients: dose -finding trial of GOIRC and GOL[J]. Ann Oncol,2006,17(1) :79 -84.
  • 7Lombardi D, Crivellari D, Scuderi C, et al. Long-term, weekly one- hour infusion of paclitaxel in patients with metastatic breast cancer: a phase Ⅱ monoinstitutional study [J]. Tumori ,2004,90 ( 3 ) :285 - 8.
  • 8Perez EA, Vogel CL, Irwin DH, et al. Multicenter phase Ⅱ trial of weekly paclitaxel in women with metastatic breast cancer[ J]. J Clin Oncol,2001,19(22) :4216 -23.
  • 9Nishimura R, Ogawa T, Kato M, et al. Weekly paclitaxel in the treatment of advanced or metastatic breast cancer previously treated or not treated with docetaxel: a phase Ⅱ study [ J ]. Chemotherapy, 2005,51 (2 -3) :126 -31.
  • 10Sato K,Inoue K, Saito T, Kai T, et al. Muhicenter phase Ⅱ trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group ( SBCCSG-01 ) [ J ]. Jpn J Clin Oncol,2003,33 ( 8 ) : 371 - 6.

共引文献60

同被引文献74

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部